SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

La Jolla Pharmaceutical Co. (LJPC)

LJPC RSS Feed
Add LJPC Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 9/30/2016 4:46:38 PM - Followers: 126 - Board type: Free - Posts Today: 0

http://www.ljpc.com/

http://finance.yahoo.com/q/h?s=LJPC

La Jolla Pharmaceutical Company, a biopharmaceutical company, engages in the research and development of pharmaceutical products in the United States. Its principal product in development is Riquent, which is designed to treat lupus renal disease by preventing or delaying renal flares. Lupus is an antibody-mediated disease caused by abnormal B cell production of antibodies that attack healthy tissues. Riquent is in Phase III clinical trial. The company also develops small molecules for the treatment of autoimmune diseases, and acute and chronic inflammatory disorders. La Jolla Pharmaceutical Company was founded in 1989 and is based in San Diego, California.  

Riquent

Riquent (abetimus sodium)

Riquent (abetimus sodium) is a synthetic oligonucleotide conjugate composed of 4 identical strands of dsDNA (20BP in length) that are linked through a triethyleneglycol-based platform. It binds anti-dsDNA Ab and the complex is cleared via the immune system, thus ridding the body of one of the primary pathogenic antibody associated with lupus.

Lupus nephritis is a serious and potentially fatal orphan disease treated primarily by nephrologists and rheumatologists. Currently, there are no products specifically approved to treat lupus renal disease.

La Jolla Pharmaceutical is investigating Riquent for the treatment of lupus renal disease by preventing or delaying renal flares, a leading cause of sickness and death in lupus patients, and improving proteinuria. Proteinuria is an indicator of abnormal renal function. Riquent has been well tolerated in all 14 clinical trials, with no overall difference in the adverse event profiles for Riquent-treated patients compared with placebo-treated patients. Riquent specifically reduces circulating levels of anti-dsDNA antibodies and is also designed to specifically suppress the B cells that make these antibodies. Decreases in these antibodies are believed to be associated with a decreased risk of renal flare. Although clinical benefit has not yet been proven, Riquent treatment has significantly reduced these antibody levels in all clinical trials in which they were measured.



 

CHARTS

 

 

3 Month Chart

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
LJPC
Current Price
Volume:
Bid Ask Day's Range
SureTrader
News News Alert: Securities Registration Statement (simplified Form) (s-3/a) 12/02/2016 05:17:39 PM
PostSubject
#2984   fast and steady profit scan LJPC bullish 23.79 stocktrademan 09/30/16 04:46:37 PM
#2983   LJPC bullish 16.32 stocktrademan 09/02/16 04:39:24 PM
#2982   Could be...but just as quickly could rebound as much starbuxsux 01/06/16 10:21:50 AM
#2981   Charts suggest La Jolla Pharmaceuticals will fall 50% http://www.thewallstreetfo longtermgems 01/06/16 09:29:48 AM
#2980   Perceptive Advisors Llc Increased La Jolla Pharmaceutical Co starbuxsux 12/02/15 03:54:33 PM
#2979   Stock offering for LJPC. Although the PPS is mauiguy2 09/10/15 09:37:29 AM
#2978   Great action here!!! ridinbulls 09/08/15 03:12:03 PM
#2977   WEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE!!!!!!!! starbuxsux 09/08/15 01:17:20 PM
#2976   La Jolla you friggin beast!!! starbuxsux 08/31/15 01:58:04 PM
#2975   My goodness starbuxsux 08/21/15 01:47:11 PM
#2974   La Jolla Pharmaceutical Company Receives Orphan Drug Designation starbuxsux 08/19/15 10:36:34 AM
#2973   La Jolla Pharmaceutical Company and Vanderbilt University Enter starbuxsux 08/19/15 10:36:04 AM
#2972   La Jolla Pharmaceutical Company Announces FDA Acceptance of starbuxsux 08/11/15 12:30:13 PM
#2971   lol... RealGenius 07/22/15 10:15:34 AM
#2970   At the time it was a bad idea...good starbuxsux 07/22/15 10:14:59 AM
#2969   Closing out my short at target $28.5. Gotta play RealGenius 07/22/15 09:41:47 AM
#2968   Bad idea starbuxsux 07/14/15 10:05:02 AM
#2967   Looks go for a short from $32 down RealGenius 07/14/15 12:37:40 AM
#2966   $60 stock soon spottrader 07/13/15 11:56:24 AM
#2965   Looking good here :) Shaka_Zulu 07/06/15 07:32:43 PM
#2964   LOL...Beautiful is an understatement...RDUS is the IRINA SHAYK starbuxsux 07/06/15 01:38:17 PM
#2963   RDUS has a beautiful chart....8 to 70 in mauiguy2 07/06/15 01:33:27 PM
#2962   Almost kissed $30 today...reminds me of RDUS...and if starbuxsux 07/06/15 01:17:36 PM
#2961   Actually. he's purchased 330,000 shares in the past mauiguy2 07/02/15 04:18:01 PM
#2960   Director Kevin C. Tang purchased 110,000 shares of starbuxsux 07/02/15 03:45:10 PM
#2959   Killer move! I can dig this. :) SPM555 07/01/15 12:38:09 PM
#2958   $LJPC - $26.80 +2.29 (+9.34%) BREAKOUT!!! WEEEEEEEEEEE!!!!!!!!!!!!!!!!!!! starbuxsux 07/01/15 09:55:01 AM
#2957   She's on faya! starbuxsux 06/29/15 01:30:55 PM
#2956   $LJPC testing a breakout today, looking strong even SPM555 06/29/15 12:26:30 PM
#2955   Yes, indeed. LJPC is looking very good today. mauiguy2 06/24/15 02:55:28 PM
#2954   $23.50 +0.96 (+4.26%)!!!!! starbuxsux 06/24/15 02:02:11 PM
#2953   NL Market Insight - LJPC NickelNothin 06/01/15 09:21:47 AM
#2952   Yea looks like $25 is around the corner starbuxsux 05/19/15 01:29:58 PM
#2951   Tang just bought another $1.78M. Essentially doubling his stake. RealGenius 05/18/15 11:41:24 PM
#2950   LJPC (NASDAQ) starbuxsux 05/18/15 12:15:37 PM
#2949   Ok I've been watching this closely...I'm not surprised starbuxsux 05/14/15 01:11:15 PM
#2948   This was unforseen, by me at least. Still Darwinian 05/08/15 03:27:22 PM
#2947   I would consider myself a long here regardless starbuxsux 05/08/15 10:11:58 AM
#2946   Green! What an amazing comeback in 36 minutes!!! mauiguy2 05/08/15 10:08:12 AM
#2945   I was thinking that you were a long mauiguy2 05/08/15 10:04:16 AM
#2944   Not taking the bait... which is why I'm starbuxsux 05/08/15 09:58:42 AM
#2943   The PPS went up $4 while I was mauiguy2 05/08/15 09:56:49 AM
#2942   Me too but glad I was out for starbuxsux 05/08/15 09:45:51 AM
#2941   Yesterday's news was the first somewhat "bad" news mauiguy2 05/08/15 09:44:34 AM
#2940   La Jolla Pharmaceutical Company Announces Portfolio Reprioritization starbuxsux 05/08/15 08:18:52 AM
#2938   La Jolla Pharmaceutical Company Appoints Lakhmir S. Chawla, starbuxsux 04/27/15 08:40:33 AM
#2937   $LJPC - $24.38 +1.34 (+5.82%) starbuxsux 04/23/15 02:15:09 PM
#2936   Agree!!!! starbuxsux 04/23/15 02:46:06 AM
#2935   More good company moves. The future looks very mauiguy2 04/22/15 09:30:50 PM
#2934   La Jolla Pharmaceutical Company Announces Additions to LJPC-401 starbuxsux 04/22/15 09:18:10 AM
PostSubject